Conneqt Health Limited (AU:CQT) — Market Cap & Net Worth
Market Cap & Net Worth: Conneqt Health Limited (CQT)
Conneqt Health Limited (AU:CQT) has a market capitalization of $15.17 Million (AU$21.43 Million) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #25792 globally and #1188 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Conneqt Health Limited's stock price AU$0.04 by its total outstanding shares 612378349 (612.38 Million). Analyse Conneqt Health Limited operating cash flow efficiency to see how efficiently the company converts income to cash.
Conneqt Health Limited Market Cap History: 2025 to 2026
Conneqt Health Limited's market capitalization history from 2025 to 2026. Data shows growth from $22.96 Million to $15.17 Million (0.00% CAGR).
Conneqt Health Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Conneqt Health Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.46x
Conneqt Health Limited's market cap is 6.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $22.96 Million | $3.55 Million | -$18.19 Million | 6.46x | N/A |
Competitor Companies of CQT by Market Capitalization
Companies near Conneqt Health Limited in the global market cap rankings as of May 6, 2026.
Key companies related to Conneqt Health Limited by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #146 globally with a market cap of $151.58 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #206 globally with a market cap of $112.99 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #228 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #245 globally with a market cap of $99.91 Billion USD ( €85.46 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #146 | Abbott Laboratories | NYSE:ABT | $151.58 Billion | $87.17 |
| #206 | Stryker Corporation | NYSE:SYK | $112.99 Billion | $295.25 |
| #228 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | XETRA:2M6 | $99.91 Billion | €66.56 |
Conneqt Health Limited Historical Marketcap From 2025 to 2026
Between 2025 and today, Conneqt Health Limited's market cap moved from $22.96 Million to $ 15.17 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$15.17 Million | -33.96% |
| 2025 | AU$22.96 Million | -- |
End of Day Market Cap According to Different Sources
On May 6th, 2026 the market cap of Conneqt Health Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.17 Million USD |
| MoneyControl | $15.17 Million USD |
| MarketWatch | $15.17 Million USD |
| marketcap.company | $15.17 Million USD |
| Reuters | $15.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more